WallStreetZenWallStreetZen

NASDAQ: SLN
Silence Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Silence Therapeutics revenue was $43.26M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $25.6M, up 1,691.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SLN annual revenue was $43.3M, with 36.7% growth year-over-year.

SLN past revenue growth

How has SLN's revenue growth performed historically?

Company
36.71%
Industry
505.6%
Market
20.84%
SLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SLN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SLN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SLN revenue history

Current Revenue
$43.3M
Current Earnings
-$45.3M
Current Profit Margin
-104.7%

Be the first to know when SLN announces revenue.

SLN Revenue History By Year

SLN Yearly RevenueSLN RevenueSLN ChangeSLN Revenue Growth
2024-12-31$43.26M$11.62M+36.71%
2023-12-31$31.64M$9.99M+46.12%
2022-12-31$21.66M$6.14M+39.54%
2021-12-31$15.52M$8.67M+126.59%
2020-12-31$6.85M$6.54M+2,145.49%
2019-12-31$305.00kN/AN/A
2018-12-31$0.00N/AN/A

1 of 1

Silence Therapeutics Revenue FAQ

What was SLN's revenue last quarter?

Silence Therapeutics (NASDAQ: SLN) reported Q4 2024 revenue of $25.58 million up 903.75% year over year. In the same quarter last year, Silence Therapeutics's revenue was $2.55 million.

What was Silence Therapeutics's revenue in 2024?

Silence Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $43.26 million, a 36.71% increase year over year.

How much does Silence Therapeutics make in a day?

Based on Silence Therapeutics annual revenue for the past five years, SLN makes an average of $65,163.56 per day.

What was Silence Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Silence Therapeutics's revenue has grown 36.71% year over year. This is 468.9 percentage points lower than the US Biotechnology industry revenue growth rate of 505.6%. Silence Therapeutics's revenue in the past year totaled $43.26 million.

How much does Silence Therapeutics make in a year?

Silence Therapeutics's revenue by year for the past five years is:
  • Silence Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $43.26 million, a 36.71% increase year over year.
  • Silence Therapeutics's annual revenue for Dec 31, 2023 was $31.64 million, a 46.12% increase from 2022.
  • Silence Therapeutics's annual revenue for 2022 was $21.66 million, a 39.54% increase from 2021.
  • Silence Therapeutics's annual revenue for 2021 was $15.52 million, a 126.59% increase from 2020.
  • Silence Therapeutics's annual revenue for 2020 was $6.85 million, a 2,145.49% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.